Globetrotting Millennial Woman Pleads Guilty to Sending $7M of Drone, Missile Parts to RussiaThe basic Instagram influencer was part of a scheme to send semiconductors to Russia to avoid U.S. sanctions.
åã®è¨äºããä¸äººç§°è¦ç¹ã®ã¢ããã³ãã£ã¼ãåç»7é¸ å´ç«ã¯ãªãé·ãå¼ã¶ã®ãï¼ãç²åã®å¸¯é»ãç¾è±¡ã®è¬ã次ã®è¨äº ç®ã«é»æ¥µãåãè¾¼ãããã¤ãªããã¯ã»ã¢ã¤ãã豪ã§éçº 2010å¹´4æ 8æ¥ ãµã¤ã¨ã³ã¹ã»ãã¯ããã¸ã¼ ã³ã¡ã³ãï¼ ãã©ãã¯ãã㯠(0) ãã£ã¼ããµã¤ã¨ã³ã¹ã»ãã¯ããã¸ã¼ Priya Ganapati Photos: Bionic Vision prototype/ BVA ãªã¼ã¹ãã©ãªã¢ã®ç 究ãã¼ã ããããã¤ãªããã¯ã»ã¢ã¤ãã®è©¦ä½åãéçºãããããã¯ãç®ã®ä¸ã«é»æ¥µã¢ã¬ã¤ãåãè¾¼ãã§ã網èã®ç¥çµç´°èã«ç´æ¥ãé»æ°çåºæ¿ãéãè¾¼ããã¨ãå¯è½ã«ãããã®ã ã Bionic Vision Australiaã¨ç§°ãããã®ç 究ãã¼ã ã¯ãéè¡æ§ã®è¦ååªå¤±ã«æ©ãæ£è ã«åãã¦ããwide-view neurostimulatorã(åºãè¦è¦ã®ç¥çµåºæ¿è£ ç½®)ã¨ããè£ ç½®ãéçºããã é»åå·¥å¦ãç¨ãã¦è¦è¦èªèã
åã®è¨äºããiPhoneã表示ãã«ã¡ããï¼èªè»¢è»ã§æ±äº¬ãç¾èµ°(åç») ãTGS2009ããå§ãã·ã§ããã³ã°ï¼ç»åã®ã£ã©ãªã¼ã次ã®è¨äº ç¥çµæ´»åãåæãã¦ãè¦ã¦ãããã®ã®åç¾ãã«æå 2009å¹´9æ30æ¥ Brandon Keim ç»åã¯Neuronè«æãããå·¦å´ã®ç»åã¯ã被é¨è ãè¦ãç»åãçãä¸ã®ç»åã¯ãå¾æ¥ã®ãæ§é ã«ç¦ç¹ããã¦ãåæã¢ãã«ããæ»ãã¦ããç»åãå³å´ã®ç»åã¯ãææ°ã®ãæ¦å¿µã«ç¦ç¹ããã¦ãåæã¢ãã«ãã«ããç»åããªãããµã¤ããããã®ç»åã¯ãååã®ç 究ãç´¹ä»ããæ¥æ¬èªçè¨äºãã ç§å¦è ãã¡ã¯ã人ã®ç²¾ç¥ãèªããã¨ã§ããã®äººãããã¾ã§è¦ã¦ãããã®ãç¥ããã¨ã«ä¸æ©è¿ã¥ãããè³ã®ãªãã§ã¤ã¡ã¼ã¸ãã©ã®ããã«è¡¨ããã¦ããããã¢ãã«åãããã¨ã§ãç¥çµæ´»åãã¿ã¼ã³ã®è¨é²ãã被é¨è ãè¦ã¦ããåçã¨çµã³ã¤ãããã¨ã«æåããã®ã ã ãã®ç 究ã¯ãã«ãªãã©ã«ãã¢å¤§å¦ãã¼ã¯ã¬ã¼æ ¡ã®ç¥çµç§å¦è Jack Gall
åã®è¨äºãå種ã®æ©å¨ãã¤ã¶ããTwitterï¼æ¥æé·ããããã·ã¥ã¢ãã è³ãããTwitterãã«ç´æ¥éä¿¡(åç») 2009å¹´4æ21æ¥ Brandon Keim 4æ1æ¥(ç±³å½æé)ã®åå¾æ©ããã¦ã£ã¹ã³ã³ã·ã³å¤§å¦ã®çç©å»å¦ã¨ã³ã¸ãã¢ã§ããAdam Wilsonæ°ã¯ããTwitterãã«ã¡ãã»ã¼ã¸ãæ稿ããããã ããå ¥åã«ä½¿ã£ãã®ã¯ä¸¡æã§ã¯ãªãè³ã ããUSING EEG TO SEND TWEETã[åµã使ã£ã¦ãããã(TWEET)ãéä¿¡]ã¨é ã®ä¸ã§èããã®ã ã ãã®ã¡ãã»ã¼ã¸ã¯ãé»è©±ãçºæããã¢ã¬ã¯ãµã³ãã¼ã»ã°ã©ãã ã»ãã«ã®ãMr. Watson, come here. I want to see you.ã[ã¯ãã½ã³åããã¡ãã«æ¥ã¦ãããä¼ãããã®ã ]ã®ç¾ä»£çã¨ããããããããªãã ãã¬ã¤ã³ï¼ã³ã³ãã¥ã¼ã¿ã¼ã»ã¤ã³ã¿ã¼ãã§ã¼ã¹(BCI)ã¯ããã¯ãåã«äººã ãé©ãããæè¡ã§ã¯ãªããèãããã¨
VisionCare's lead product is the Implantable Miniature Telescope (IMTÂ by Dr. Isaac Lipshitz), currently in Phase II/III clinical trials for central vision loss due to age-related macular degeneration (AMD). This visual prosthetic device is designed to improve vision and quality of life for individuals with moderate to profound vision loss caused by dysfunction of the macula. The macula is a small
ãè³ãå¢å¼·ããè¬ãåæ³åã主張ãããNatureãè«èª¬ 2008å¹´12æ15æ¥ ãµã¤ã¨ã³ã¹ã»ãã¯ããã¸ã¼ç¤¾ä¼ ã³ã¡ã³ãï¼ ãã©ãã¯ãã㯠(0) Brandon Keim Image: Todd Page è³ã®åããå®å ¨ã«é«ãã¦ãããè¬ãããã®ãªãããªã使ããªãã®ã ãããï¼ èªåã使ããããªãããã¨ãã£ã¦ããªãä»äººã®ä½¿ç¨ã¾ã§æ¢ããã®ã ãããï¼ æ績ãä»äºã®è©ä¾¡ãä¸ããããããæ¬æ¥ãªã注ææ¬ é¥é害ã®æ£è ã«å¦æ¹ãããè¬ãããã®ç®çã¨ã¯éã£ãæå³ã§æ¥å¸¸çã«ãéæ³ã«æç¨ãã¦ãã人ã ãåå¨ããä¸ã§ã¯ãããããå«ççãªåããããæå®ãå¾ããã®ã«ãªãã ãNatureãèªããã1ã¤ã®çããæ示ããããå«çå¦ãç¥çµç§å¦ã®åéã§èåãª7人ã«ãã£ã¦ã12æ11æ¥å·ã«æ²è¼ãããè«èª¬ãèªèè½åå¢å¼·è¬ã®ãå¥åº·ãªäººã«ãã責任ãã使ç¨ã«åãã¦ãã ã çµè«ãè¨ãã°ãåæ³åãã¹ãã¨ãããã¨ã ã ã責任è½åãããæ人ã¯ãè¬ã«
Expiredï¼æ²è¼æéåãã§ã ãã®è¨äºã¯ï¼ãã¤ã¿ã¼ã»ã¸ã£ãã³ã¨ã®å¥ç´ã®æ²è¼æéï¼30æ¥éï¼ãéãã¾ããã®ã§æ¬ãµã¼ãããåé¤ãã¾ããã ãã®ãã¼ã¸ã¯20ç§å¾ã«News ããããã¼ã¸ã«èªåçã«åãæ¿ããã¾ãã
ãã³ãéçºãç°¡åã«è£ çã§ãããå¤éª¨æ ¼ãï¼ç»åã¨åç»ã§ç´¹ä» 2008å¹´11æ11æ¥ ãµã¤ã¨ã³ã¹ã»ãã¯ããã¸ã¼ ã³ã¡ã³ãï¼ ãã©ãã¯ãã㯠(0) Jason Sattler Photo credit: æ¬ç°æç å·¥æ¥(以ä¸åæ§ãåç»ã) æ¬ç°æç å·¥æ¥(ãã³ã)ã®ããããå·¥å¦ãªã¿ã¯ãã¡ããé´ã®ããã«è£ çãã¦èº«ä½ãæ¯ããé¢ç¯ãä¿è·ãããå¤éª¨æ ¼ããéçºããããã³ãã«ããã¨ãå·¥å ´ã®çµç«ã©ã¤ã³ã§ã®ã±ã¬ãæ¸ããå¹æãæå¾ ã§ãããã®ã§ãããã«ãé«é½¢è ã®åãã楽ã«ããç¨éãèããããã¨ããã ãã®æ©å¨ã¯ãèªè»¢è»ã®ãµãã«ãé´ã«åãä»ãããããªå¤è¦³ã§ãèã®éã«ãã£ããããä½ãã«ãªã£ã¦ããããããè£ çãããã¨ã§ãæ©ãããããããç«ã¤ãªã©ã®åä½ããè¡é¢ç¯ãèé¢ç¯ã足é¦é¢ç¯ã«ä½è¨ãªè² æ ãããããã¨ãªãè¡ããã¨ãã§ããã ãã³ãã¯ãã®ãä½éæ¯æåæ©è¡ã¢ã·ã¹ãã試ä½æ©ã®æå¹æ§ããå¼çççå±±å¸ã«ããå¼ç製ä½æã®è»ä¸¡çµç«ã©ã¤ã³
æ±å¤§ã®ç 究ãã¼ã ãéæè¶ é³æ³¢ã§ãè¦ããªãç©ä½ãã®æ触ãå®ç¾(åç») 2008å¹´9æ 5æ¥ ãµã¤ã¨ã³ã¹ã»ãã¯ããã¸ã¼ ã³ã¡ã³ãï¼ ãã©ãã¯ãã㯠(0) Brian X. Chen æ¥æ¬äººã®ç 究è ãã¡ããç®ã«ã¯è¦ããªããã触ããããã³ã³ããã¼ã«ãããã¨ã®ã§ããç©ä½ãä½ãåºãæè¡ãéçºããã æ±äº¬å¤§å¦ã®ç 究è [æ å ±çå·¥å¦ç 究ç§ã®ç¯ ç°è£ä¹åææã岩æ¬è²´ä¹ç 究å¡ã]ã«ãã£ã¦èæ¡ããããã®ã·ã¹ãã ã¯ãè¤æ°ã®è¶ é³æ³¢ãæä½ãã¦ç¦ç¹ãä½ãåºããã¨ã§ã人éã®æããç©ä½ããæããããããã«ããã ã¾ããæã®ä½ç½®ã追跡ããã«ã¡ã©ã使ç¨ããæã®å¨å²ã§ç¦ç¹ã移åããããã¨ã§ããã¼ãã£ã«ãªç©ä½ã®è¡¨é¢ããã¬ã¼ã¹ã§ããããã«ããã ç 究è ãã¡ã«ããã¨ããã®æè¡ããããªã²ã¼ã ã«å¿ç¨ãããã¨ã§ãã²ã¼ãã¼ãã¡ã¯ã³ã³ããã¼ã©ã¼ãã¸ã§ã¤ã¹ãã£ãã¯ãªã©ãè³¼å ¥ããå¿ è¦ããªããªããããããªãã¨ãããããã¯ç´ æ´ãããï¼ ã¢ãã¿ã¼ãå¦åãã
ãã©ã¶ã¼å·¥æ¥ã¯ã網èã«å ãå½ã¦ã¦æ åãæ ããç¼é¡åã®ç¶²èèµ°æ»ãã£ã¹ãã¬ã¤ï¼RIDï¼Retinal Imaging Displayï¼ã2010å¹´ã«çºå£²ããè¨ç»ã ãã¾ãã¯æ³äººåãã«å±éãããã£ã¹ãã¬ã¤ã«åè·¯å³ãæå½±ããªããå·¥äºããããã«ã«ããæ ããªããæè¡ããã¨ãã£ãå©ç¨ãè¦è¾¼ãã§ããã 9æ4æ¥ã«æ±äº¬ã§éãããã©ã¤ãã¼ãã·ã§ã¼ãBrother World JAPAN 2008ãï¼æ±äº¬å½éãã©ã¼ã©ã ï¼ã§ã¢ãã¯ã¢ãããå±ç¤ºããã RIDã¯ãç®ã«å ¥ãã¦ãå®å ¨ãªæããã®å ã網èã«å½ã¦ããã®å ãé«éã«åãããã¨ã«ããæ®åå¹æãå©ç¨ãã網èã«æ åãæå½±ããæè¡ã å¾æ¥ã®ããããã¦ã³ããã£ã¹ãã¬ã¤ã¨ç°ãªããç®ã«ç´æ¥å ãå½ã¦ããããå°å液æ¶ãã£ã¹ãã¬ã¤ãªã©ã¯ãªããç¼é¡åã¨ãã£ã¦ãã¬ã³ãºããªããç®ã®åã«ããã®ã¯ééåã®åå°æ¿ã ããæ åã®åããã«ã¯å¤ã®æ¯è²ãéãã¦è¦ããã ç¼é¡ã«è£ çããæå½±é¨ã¯25ã°ã©ã ã¨è»½ã
è³ã¨ã³ã³ãã¥ã¼ã¿ã¼ãç´çµããã¤ã³ã¿ã¼ãã§ã¼ã¹ãç¾å®ã« 2004å¹´1æ16æ¥ ã³ã¡ã³ãï¼ ãã©ãã¯ãã㯠(0) Kristen Philipkoskiã2004å¹´01æ16æ¥ ãµã³ãã©ã³ã·ã¹ã³çºââç ©ããããã¼ãã¼ããã¸ã§ã¤ã¹ãã£ãã¯ãªãã¦æ¾ãåºãã¦ãèªåã®è³ãç´æ¥ã³ã³ãã¥ã¼ã¿ã¼ã«ã¤ãªãããããããã®ã«ãã¨æã£ã¦ãã人ã¯å¤ãââã¨ãã«ããã¼ãã¼ããã¸ã§ã¤ã¹ãã£ãã¯ã使ããªã人ã¯ããã ããã ããµãã¥ã¼ã»ããå·ãã©ãã¯ã¹ããã«ããæ ªå¼æªå ¬éä¼æ¥ããµã¤ãã¼ãããã£ãã¯ã¹ç¤¾ãèæ¡ããããã¬ã¤ã³ï¼ã³ã³ãã¥ã¼ã¿ã¼ã»ã¤ã³ã¿ã¼ãã§ã¼ã¹ã(BCI)ã¯ãã®å¤¢ãå®ç¾ãã¦ããããã®ã§ãæ°ãµæå¾ã«ã¯åè¢éº»çºæ£è 5人ã対象ã«è¨åºè©¦é¨ãè¡ãªããããããããªãã ããã¬ã¤ã³ã²ã¼ãã(BrainGate)ã¨ãããã®ã·ã¹ãã ã使ãã°ãåè¢ãå ¨ãåããªã人ã§ããæèããéã«çããè³å ä¿¡å·ã ããå©ç¨ãã¦ãã³ã³ãã¥ã¼ã¿ã¼ãããã
ããããã¯äººéãè³ã«ãããªãããã1ååãè¾¼ãã ãã§ã塾ã«éããªãã¦ãæ±å¤§ã«å ¥ããããã«ãªããã§ããããâ¦ã ããã¯çããè³ç´°èã«è©±ããããå²ä¸åã®ã·ãªã³ã³ãããã§ããå ¨ç±³ã®ç¥çµç§å¦è ãæ°å¦è ãã³ã³ãã¥ã¼ã¿ã¨ã³ã¸ãã¢ããã¤ãªã¨ã³ã¸ãã¢ã®åªç§ãªé è³ãéã¾ã£ã¦ç·¨æãããåã«ãªãã©ã«ãã¢å¤§å¦ï¼USCï¼ã®ç¥çµç§å¦ç 究ãã¼ã ãä½ãã¾ããã ãããã¯ç´1å¹³æ¹ããªã®è¶ å°åãã¾ãã§ä½ã®ä¸é¨ã®ããã«æ©è½ãã¾ãã移æ¤ã¯ã¾ã ç¡çã§ããã人éã®è³ç¥çµã1000åãã¥ã¼ãã³ãããã®ã«å¯¾ãã¦ãããã¯ãã£ãã®1ä¸2000ãã¥ã¼ãã³ãããªãã§ããã©ã ãã¼ã ã®ç®æ¨ã¯ï½¢ãã¤ã人éã®è¨æ¶ãä¿åã§ããæ©æ¢°ãã¤ãããã¨ï½£ãï¼åé¨çã®è³ã®ã¢ããã°ã¬ã¼ãã¯ãã¦ããï¼è³ã«é害ã®ãã人ããã¢ã«ããã¤ãã¼ã®æ£è ãããã¡ã念é ã«éçºãã¦ããããã§ããï¼ è³ã«åãããããããã¯ãã®å®ç¾ã¸ã®ç¬¬ä¸æ©ã é ã«ãããªãããå ¥ãã¦æ©ãåãã¨ããã®ã¯Sc
ããã失ã£ãè¨æ¶ã人工ããããè³ã«åãè¾¼ããã¨ã§åãæ»ããã¨ãã§ããããã«ãªããããããªããåã«ãªãã©ã«ãã¢å¤§å¦ã®ç 究ãã¼ã ã¯ãã©ããã®å·ã¤ããè³çµç¹ã人工ç¥çµãããã¨å ¥ãæ¿ããæè¡ãéçºããã æ¥çµãµã¤ã¨ã³ã¹4æå·ã«ããã¨ãããã¾ã§ã®ç 究ã§è³ããéãããä¿¡å·ã«åºã¥ãã¦ããããã¢ã¼ã ãå¶å¾¡ããããã³ã³ãã¥ã¼ã¿ã®ã«ã¼ã½ã«ãåããã¦ã¡ãã»ã¼ã¸ãæ¸ãããã§ãããããªã£ã¦ãããããã«å¯¾ãã¦åã«ãªãã©ã«ãã¢å¤§å¦ã®Theodore Bergerææãã¯è³ããæ å ±ãåãåãã ãã§ãªãè³ã¸éãåºããã¨ãã§ããåã®è³ã»æ©æ¢°ã¤ã³ã¿ã¼ãã§ã¼ã¹ãéçºããã1åã®ã·ãªã³ã³ãããã使ã£ã¦ãã©ããã®è³ã®ä¸é¨ã海馬ã«ããè³ç¥çµã模å£ããããã®æ¥ã«ãã©ããã使ã£ãå®é¨ãå§ããäºå®ãæçµçã«1ããªåæ¹ã«å°ååããåãè¾¼ã¿ãããã製ä½ããã å ±åç 究è ã®ã¦ã§ã¤ã¯ãã©ã¬ã¹ã大å¦Sam Deadwylerææã¯ãããç¹å®ã®ç¥çµ
ãã³ã¿ã´ã³ãç±³å µã®å¥åº·ç¶æ ãåå æä¸ç£è¦ã§ãããããè³ã«åãè¾¼ã¿å¯è½ãªï½¢ãã¤ãªãããï½£ã®éçºãé²ãã¦ããããã§ãã ãã®ç±³ç²å¤§ã®ããããããã ã¯ã¬ã ã¾ã³å¤§å¦éå±C3Bï¼ãã¤ãªé»åã»ãã¤ãªã»ã³ãµã»ãã¤ãªãããç 究æï¼ãä½ãã¾ããã ãããé ã«åãè¾¼ãã§ããã°ãåç·ã§ãã¿ãã¨æããã¦æ°ã失ã£ã¦äº¤ä¿¡ä¸è½ã«ãªã£ã¦ããããããæ å ±ãéããã¦ãä½ã®çå½ç¶æå¨å®ã®ç¶æ ãå»å¸«å£ã«çæãã«ã æè¡ç観ç¹ããã©ãããããããªã®ãã¯ä¸æã§ããã©ãæä½ã§ãçèã®é ¸ç´ ã¬ãã«ã¯è¨æ¸¬å¯è½ã«ãªãããã§ããï¼ é»åæè¡ã¨ã¯é¢ä¿ãªãé²æ©ãã¨ããã¯ãªãã§ãã 人éã®çèãçä¼¼ãã¸ã§ã«ãã§ããããã ããããã¨ãã¤ã¯ãããããä½µç¨ããã°çèã®æå¦åå¿ã®çºççãä¸ããã®ã§ã¯ï¼ å½é²ç·çã§ã¯5年以å ã«è¨åºãè¡ããæ¸ã¿æ¬¡ç¬¬ãå®ç¨åãç®æãããæåã§ãã è»äººãããã¡ã¯â¦ãã¡ããå«ãã£ã¦ãããã§ããï¼ ãªãã®ã¨ããä½ã®ç¶æ ãè¦å¼µããããª
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}